ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice

Radhika Mathur1,2, Burak H Alver3, Adrianna K San Roman1,4

  • 1Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA.

Nature Genetics
|December 13, 2016
PubMed

Insights

ARID1A acts as a tumor suppressor in the mouse colon, preventing colorectal cancer (CRC) by regulating gene expression at enhancers. Its loss leads to invasive ARID1A-deficient adenocarcinomas, highlighting a novel mechanism in CRC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SWI/SNF (BAF) chromatin-remodeling complexes are frequently mutated in human cancers (~20%).
  • ARID1A is the most commonly mutated subunit, but its role in tumorigenesis is not fully understood.
  • APC/β-catenin signaling is critical in common intestinal cancers.

Purpose of the Study:

  • To investigate the tumor-suppressive function of Arid1a in the mouse colon.
  • To understand the mechanism by which ARID1A inactivation promotes colorectal cancer (CRC).
  • To explore the role of ARID1A in regulating gene expression via chromatin remodeling.

Main Methods:

  • Utilized mouse models to study Arid1a function in the colon and small intestine.
  • Generated and characterized ARID1A-deficient adenocarcinomas.
  • Analyzed gene expression and chromatin accessibility in ARID1A-deficient tumors.
  • Investigated the targeting of SWI/SNF complexes to enhancers.

Main Results:

  • Arid1a functions as a tumor suppressor in the mouse colon, but not the small intestine.
  • ARID1A-deficient adenocarcinomas in mice closely resemble human CRC and lack APC/β-catenin pathway alterations.
  • ARID1A targets SWI/SNF complexes to enhancers, coordinating with transcription factors for gene activation.
  • ARID1B compensates for ARID1A loss, but SWI/SNF targeting and enhancer control are impaired, leading to widespread gene dysregulation.

Conclusions:

  • ARID1A inactivation promotes tumorigenesis in the colon through dysregulation of enhancer-mediated gene expression.
  • ARID1A's tumor-suppressive function is primarily linked to its role in controlling gene regulation at enhancers.
  • This study provides a new model for colon cancer and implicates enhancer regulation in ARID1A-driven tumor suppression.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K